logo

For the Inventor, By the Inventor

Yountville, CA, United States of America

Reynolds G Gorsuch

This inventor holds 29 USPTO granted patents and 1 EPO patent, primarily in Plasmapheresis Technology. Top assignees: Transvivo, Inc., Healthdyne, Inc., Matria Healthcare, Inc.. Active years: 1990-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reynolds G Gorsuch. Retrieved from https://idiyas.com/inventor/reynolds-g-gorsuch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 29

% Patents Active = 48.3


Average Co-Inventor Count = 1.9

ph-index = 19

Forward Citations = 1,820(Granted Patents)


Company Filing History:

goldMedal19 out of 19 
 
Transvivo, Inc.
 patents
silverMedal6 out of 15 
 
Healthdyne, Inc.
 patents
bronzeMedal2 out of 4 
 
Matria Healthcare, Inc.
 patents
4. 1 out of 1 
 
Heathdyne, Inc.
 patent
5. 1 out of 834,601 
Other
 patents

Years Active: 1990-2011

Loading Chart...
Loading Chart...
Areas of Expertise:
Plasmapheresis
Hollow Fiber Membranes
Fluid Management
Apheresis
Ultrafiltration
Hemodialysis
Plasma Separation
Biomedical Devices
Blood Parameters
Tissue Engineering
Dialysis
Patient Monitoring
29 patents (USPTO):Explore Patents
1. 8070706 - Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant (2011-12-06),
2. 7585412 - Specialized hollow fiber membranes for plasmapheresis and ultrafiltration (2009-09-08),
3. 7572374 - Anticoagulant and thrombo-resistant hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2009-08-11),
4. 7481936 - Method and apparatus for patient fluid management (2009-01-27),
5. 7476210 - Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant (2009-01-13),
6. 7354392 - Structurally optimized hollow fiber membranes (2008-04-08),
7. 7267771 - Apparatus for therapeutic apheresis (2007-09-11),
8. 7195711 - Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2007-03-27),
9. 6949078 - Apparatus and method for selective reduction of segmental intracellular and extracellular edema (2005-09-27),
10. 6899692 - Plasmapheresis filter device and catheter assembly (2005-05-31),
11. 6849183 - Method and apparatus for therapeutic apheresis (2005-02-01),
12. 6802971 - Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2004-10-12),
13. 6802820 - Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2004-10-12),
14. 6659973 - Apparatus and method for in-vivo plasmapheresis using periodic backflush (2003-12-09),
15. 6632192 - Apparatus and method for selective reduction of segmental intracellular and extracellular edema (2003-10-14),

Title: The Innovative Journey of Reynolds G. Gorsuch

Introduction: Reynolds G. Gorsuch is a distinguished inventor based in Yountville, California, known for his groundbreaking contributions to various industries.

Latest Patents: Reynolds G. Gorsuch holds several patents in the fields of technology, healthcare, and consumer goods, showcasing his versatility and creativity.

Career Highlights: With a career spanning over two decades, Gorsuch has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Reynolds G. Gorsuch has collaborated with leading companies, research institutions, and universities to bring his ideas to life, fostering a culture of innovation and excellence.

Conclusion: Reynolds G. Gorsuch's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving a lasting impact on the world of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…